Symbols

SVRA

Savara·NASDAQ

--(--)

SVRA Profile

Savara Inc.

A biopharmaceutical company that develops and commercializes therapies for rare respiratory diseases

Industry

Biological Technology

Established Date

Listing Date

04/28/2017

Exchange

NASDAQ Stock Exchange

Full-time Employees

Fiscal Year Ends

12-31

Website

www.savarapharma.com

Security Type

Common stock

Office address

1717 Langhorne Newtown Road, Suite 300 Langhorne, Pennsylvania 19047

Business

Introduction

Savara Inc., was incorporated in Delaware in December 1995. The company is a clinical-stage biopharmaceutical company focused on rare respiratory diseases. Its only program, molgramostim inhalation solution (MOLBREEVI), is an investigational inhaled biologic that is in Phase 3 development for the treatment of autoimmune pulmonary alveolar proteinosis and has received Fast Track, Breakthrough Therapy and Orphan Drug designation.